For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260331:nRSe8448Ya&default-theme=true
RNS Number : 8448Y Angola (The Republic of) 31 March 2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE SUCH
RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL
THE REPUBLIC OF ANGOLA ANNOUNCES THE RESULTS OF THE TENDER OFFER FOR ITS
8.25 PER CENT. NOTES DUE 2028
31 March 2026 - The Republic of Angola (the "Republic" or the "Angola")
today announces the results of its invitations to eligible holders of its
outstanding 8.25% Notes due 2028 (Reg. S ISIN: XS1819680288; Reg. S Common
Code: 181968028; Rule 144A ISIN: US035198AB62; Rule 144A CUSIP: 035198AB6;
Rule 144A Common Code 181968087) (the "Existing Notes") to tender such
Existing Notes for purchase by the Republic for cash (the "Offer"). The Offer
was announced on 24 March 2026 and was made on the terms and subject to the
conditions set out in the tender offer memorandum dated 24 March 2026 (the
"Tender Offer Memorandum") prepared by the Republic. Capitalised terms used
but not otherwise defined in this announcement shall have the meanings given
to them in the Tender Offer Memorandum.
The Expiration Deadline for the Offer was 5.00 p.m. (New York City time)
on 30 March 2026.
As at the Expiration Deadline, the Republic had received valid tenders of
U.S.$893,827,000 in aggregate principal amount of Existing Notes for purchase
pursuant to the Offer.
On 31 March 2026, the Republic successfully completed the issuance of (i)
U.S.$1,500,000,000 9.375 per cent. Notes due 2033; and (ii) and
U.S.$1,000,000,000 9.875 per cent. Notes due 2037, meaning that the New
Financing Condition has been satisfied. Accordingly, the Republic will accept
for purchase U.S.$490,197,000 in aggregate principal amount of Existing Notes
with a proration factor of 0.527810. The aggregate Purchase Price for all
Existing Notes accepted for purchase will be U.S.$500,000,940.00.
The Tender Consideration is U.S.$1,020.00 per U.S.$1,000 in principal amount
of such Existing Notes plus the Accrued Interest on such Existing Notes. The
Settlement Date in respect of the Existing Notes accepted for purchase will be
1 April 2026. All Existing Notes accepted for purchase will be cancelled and
will not be reissued or resold. Any Existing Notes that were not tendered or
are not accepted for purchase pursuant to the Offer will remain outstanding.
Disclaimer
This announcement does not contain the full terms and conditions of the
Offer. The terms and conditions of the Offer are contained in the Tender
Offer Memorandum, and are subject to the offer restrictions set out below and
more fully described therein.
Further information
Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, J.P. Morgan
Securities plc and Standard Chartered Bank (together, the "Dealer Managers")
have been appointed by the Republic to serve as dealer managers for the Offer.
Citibank N.A., London Branch (the "Tender Agent") has been appointed by the
Republic to act as the tender agent in connection with the Offer.
For additional information regarding the terms of the Offer, please contact
Citigroup Global Markets Limited by email at
liabilitymanagement.europe@citi.com or by telephone at +44 20 7986 8969
(Europe) / +1 (800) 558 3745 (U.S. Toll Free) / +1 (212) 723 6106 (U.S.),
Deutsche Bank AG, London Branch by telephone at +44 20 7545 8011, J.P. Morgan
Securities plc by email at em_europe_lm@jpmorgan.com or by telephone at +44 20
7134 2468 and Standard Chartered Bank by email at liability_management@sc.com
(mailto:liability_management@sc.com) or by telephone at +44 20 7885 5739.
Requests for documents and questions regarding the tender of Existing Notes
may be directed to the Tender Agent via email: citiexchanges@citi.com or
telephone: London: +44 20 7508 3867.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RTEVFLBXQXLEBBE
Copyright 2019 Regulatory News Service, all rights reserved